Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Sanguina Scores $2.8M Series A Funding

PEACHTREE CORNERS, GA, Sanguina, a leading biotech company focused on providing rapid home-based testing and management solutions, has completed a $2.8 million Series A funding round.
Led by Veritus Holdings, the round saw participation from notable investors, including George Hornig of The Seed Lab and Stephen Ippolito of Veritus Holdings. The funding will be used to accelerate the development and expansion of Sanguina's innovative blood health management digital and at-home-based platforms.

Sanguina is a leading biotech company focused on advancing accessible digital and at-home health platforms for rapid home-based testing and disease management. Founded in 2019, Sanguina aims to empower individuals by providing innovative solutions for diagnosing, monitoring, and managing wellness and chronic conditions. With a team of experienced scientists, engineers, and healthcare professionals, Sanguina is committed to positively impacting global healthcare.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors